Pacific Biosciences
PACB
#6536
Rank
โ‚น49.24 B
Marketcap
โ‚น167.32
Share price
-3.90%
Change (1 day)
-78.08%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2024 (TTM): โ‚น14.44 Billion

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚น14.70 Billion. In 2023 the company made a revenue of โ‚น16.69 Billion an increase over the revenue in the year 2022 that were of โ‚น10.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น14.44 B-13.48%
2023 โ‚น16.69 B57.23%
2022 โ‚น10.61 B9.29%
2021 โ‚น9.71 B68.36%
2020 โ‚น5.76 B-10.98%
2019 โ‚น6.48 B17.89%
2018 โ‚น5.49 B-7.88%
2017 โ‚น5.96 B-3.19%
2016 โ‚น6.16 B-0.02%
2015 โ‚น6.16 B60.55%
2014 โ‚น3.84 B120.59%
2013 โ‚น1.74 B22.37%
2012 โ‚น1.42 B-20.58%
2011 โ‚น1.79 B2288.09%
2010 โ‚น75.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น372.85 B 2,435.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.79 B-6.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.621 T 31,324.74%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.598 T 24,370.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น285.15 B 1,839.08%๐Ÿ‡บ๐Ÿ‡ธ USA